Clinical Trial Update: DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for DLBS2411 in non-bleeding peptic ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-bleeding Peptic Ulcers

Drugs mentioned

• DLBS2411

Snippet

Sponsor: Dexa Medica Group | Conditions: Non-Bleeding Peptic Ulcers | Phase 3 | Status: TERMINATED